For the purposes of this Regulation:
‘medicinal product’ means a medicinal product for human use, as defined in Article 2 of Directive 65/65/EEC;
‘orphan medicinal product’ means a medicinal product designated as such under the terms and conditions of this Regulation;
‘sponsor’ means any legal or natural person, established in the Community, seeking to obtain or having obtained the designation of a medicinal product as an orphan medicinal product;
‘Agency’ means the European Agency for the Evaluation of Medicinal Products.